|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.010 HKD | -5.61% |
|
-13.68% | +26.25% |
| 06-26 | Fusen Pharma Gets Marketing Nod for Influenza Drug in China | MT |
| 06-19 | Fusen Pharma Unit to Raise 300 Million Yuan From State-Owned Investors | MT |
| Market Cap | 643M 747M 95.22M 82.78M 77.05M 70.74M 134M 9.09B 136M 908M 356M 4.53B 358M 350M 15.17B | P/E 2024 |
-2.95x | P/E 2025 | -45.1x |
|---|---|---|---|---|---|
| Enterprise Value | 865M 1B 128M 111M 104M 95.15M 180M 12.23B 182M 1.22B 479M 6.09B 481M 470M 20.41B | EV / Sales 2024 |
2.83x | EV / Sales 2025 | 2.76x |
| Free-Float |
26.11% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -5.61% | ||
| 1 week | -13.68% | ||
| 1 month | -5.61% | ||
| 3 months | -10.62% | ||
| 6 months | +38.36% | ||
| Current year | +26.25% |
| 1 week | 1 |  | 1.17 |
| 1 month | 0.85 | | 1.2 |
| Current year | 0.68 | | 1.44 |
| 1 year | 0.3 | | 1.75 |
| 3 years | 0.24 | | 1.75 |
| 5 years | 0.24 | | 3.48 |
| 10 years | 0.24 | | 20 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zhen Li
DFI | Director of Finance/CFO | 48 | 18/04/2019 |
Zhi Ming Cao
IRC | Investor Relations Contact | 40 | 18/01/2013 |
Yuk Hong Yeung
SEC | Corporate Secretary | 36 | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Tai Sheng Hou
BRD | Director/Board Member | 63 | 07/04/2017 |
Yong Sheng Chi
BRD | Director/Board Member | 64 | 07/04/2017 |
Qing Fen Meng
BRD | Director/Board Member | 61 | 07/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 19/4/24 | Other | Chairman | 650,000 | 0.0867% | ||
| 18/4/24 | Other | Chairman | 240,000 | 0.0320% | ||
| 18/4/24 | Other | Chairman | 240,000 | 0.0320% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.61% | -13.68% | +180.56% | -32.21% | 95.22M | |
| -0.53% | +2.54% | +16.63% | +74.09% | 50.03B | |
| -1.81% | -0.49% | +51.99% | +112.44% | 36.6B | |
| +0.46% | +4.44% | -5.24% | +25.38% | 12.47B | |
| +1.05% | +1.63% | +16.19% | +78.22% | 11.77B | |
| -1.33% | -0.76% | +30.08% | +131.70% | 9.04B | |
| -2.99% | -2.09% | +41.02% | -8.36% | 7.03B | |
| +0.51% | +1.46% | +12.17% | +32.88% | 6.79B | |
| -.--% | +0.14% | - | - | 6.79B | |
| +1.99% | +1.91% | +4.68% | +183.54% | 6.6B | |
| Average | -0.83% | -0.47% | +38.67% | +66.41% | 14.72B | |
| Weighted average by Cap. | -0.62% | +1.26% | +25.29% | +82.77% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 326M 378M 48.27M 41.96M 39.05M 35.86M 67.71M 4.61B 68.76M 460M 181M 2.29B 181M 177M 7.69B | 273M 317M 40.47M 35.18M 32.75M 30.06M 56.77M 3.86B 57.65M 386M 151M 1.92B 152M 149M 6.45B |
| Net income | -189M -219M -27.95M -24.3M -22.61M -20.76M -39.21M -2.67B -39.81M -267M -105M -1.33B -105M -103M -4.45B | -11.78M -13.68M -1.74M -1.52M -1.41M -1.3M -2.45M -167M -2.49M -16.64M -6.53M -82.91M -6.55M -6.41M -278M |
| Net Debt | 367M 426M 54.37M 47.26M 43.99M 40.39M 76.27M 5.19B 77.45M 519M 204M 2.58B 204M 200M 8.66B | 222M 258M 32.86M 28.57M 26.59M 24.41M 46.1M 3.14B 46.82M 313M 123M 1.56B 123M 121M 5.24B |
Employees
1,005
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 31/07/26 | HK$1.010 | -5.61% | 36,000 |
| 30/07/26 | HK$1.070 | -.--% | 0 |
| 29/07/26 | HK$1.070 | +0.94% | 193,000 |
| 28/07/26 | HK$1.060 | -.--% | 69,000 |
| 27/07/26 | HK$1.060 | -9.40% | 370,000 |
- Stock Market
- Stocks
- 1652 Stock
Select your edition
All financial news and data tailored to specific country editions
